立体中心
部分
候选药物
组合化学
烷基化
铃木反应
化学
羧化
药物发现
衍生工具(金融)
药物开发
立体化学
药品
药理学
有机化学
对映选择合成
生物化学
医学
催化作用
体外
金融经济学
经济
钯
作者
Christophe Hardouin,Sandrine Baillard,François Barière,Chloé Copin,Anthony Craquelin,Solenn Janvier,Sylvain Lemaitre,Stéphane Roux,Olivier Russo,Sébastien Samson
标识
DOI:10.1021/acs.oprd.9b00364
摘要
Our efforts toward the process development of drug candidate 1 are described in a series of two papers. This manuscript focuses on the synthesis of kilogram quantities of acid precursor 2 to provide batches of material for preclinical studies and first-in-human clinical trials. Our approach relies on a chiral resolution to furnish the desired stereocenter, a cryogenic carboxylation, and N-alkylation of chloride derivative 26 prepared by a Suzuki coupling. Further efforts pursued to improve those key steps that could become issues on larger scale are also discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI